EN DE

Ultralife Corporation (ULBI) Fair Value & Analysis

Industrials · US · Market cap $104M

UC Ultralife Corporation logo Ultralife Corporation ULBI · US
Price$6.35
Fair Value$5.02
Upside-20.9%
Quality48/100
Watch Ultralife Corporation for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Loss-making · -4.4% net margin
Low debt · generates free cash flow
Trails peers (4/13)
Narrow moat 21/100
Evidence: High Range $2.24 – $8.61 Share as image

Fair value as of: Jul 21, 2026

From 15 valuation models · updated 20 days ago

Share price +8.9% over the past month.

Below-average quality, and screening another 21% overvalued on our models.

What matters now

  • The model range is unusually wide ($2.24 to $8.61). The outcome hinges heavily on assumptions, so read the point estimate with caution.
  • Solid but not exceptional quality (48/100) and above fair value, neither a clear bargain nor a standout compounder.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$13.25 $3.70 Fair Value $5.02 Apr 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 21, 2026.

How to read this chart

60‑month range $3.70 – $13.25 · fair‑value band $2.24 – $8.61 · the $6.35 price screens above the $5.02 fair value. Dashed = 300-day average. As of Jul 21, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Ultralife Corporation (ULBI) currently trades at $6.35, while our model-based Fair Value estimate is $5.02, implying the stock looks roughly 20.9% overvalued today. The Quality Score stands at 48/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Ultralife Corporation generated revenue of $188M at a net margin of -4.4%. Revenue declined 6.5% year over year. It earns a return on equity of -6.2%. Net debt stands at $40.3M. Fundamentals as of Jul 21, 2026

Our scenario range runs from $2.24 (bear case) to $8.61 (bull case); at $6.35, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 33% below its 52-week high and 30% above its 52-week low, currently below its 200-day average. For context, the median of 10 Industrials peers we cover trades at -48% fair-value upside, at -21%, ULBI screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF $1.46 $2.80 $4.41 80
Rev-Margin DCF $2.12 $4.79 $7.95 74
ROIC Compounder $1.39 $1.81 $2.16 72
All 15 models by family
DCF Models
FCF DCF $1.47 $3.05 $5.09 38
5Y Revenue Exit $2.12 $4.81 $8.28 39
5Y EBITDA Exit $3.75 $7.91 $12.87 41
10Y Revenue Exit $1.66 $3.82 $6.78 36
10Y EBITDA Exit $2.67 $5.68 $9.84 37
Earnings-Based
EPV $1.39 $1.81 $2.16 59
Dividend Discount
Gordon GGM $0.0100 $0.0100 $0.0100 70
DDM Multi-Stage $0.0100 $0.0100 $0.0100 61
Multiples
EV/EBIT $4.89 $7.24 $9.59 53
EV/EBITDA $6.44 $9.32 $12.19 54
EV/Revenue $2.86 $5.02 $7.18 43
Asset-Based
NCAV (Graham) $3.90 $5.23 $7.80 50
Growth DCF
Growth DCF $1.46 $2.80 $4.41 80
Rev-Margin DCF $2.12 $4.79 $7.95 74
Economic Profit
ROIC Compounder $1.39 $1.81 $2.16 72

Widest divergence: Multiples ($7.24) versus Dividend Discount ($0.0100). Highest evidence: Growth DCF (80).

Notify me when ULBI reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) $188M
Revenue growth (YoY) -6.5%
Net margin -4.4%
Return on equity -6.2%
Free cash flow $7.1M FY2025
Operating margin 1.3%
More key figures
EPS (TTM) $-0.4900
EPS growth (YoY) -72.1%
Net debt $40.3M FY2025

Figures from reported company fundamentals · as of Jul 21, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 48/100

Of which business quality 48 · Market factors (momentum, volatility) 30

Profitability 22
Margins and returns on capital today
Quality Growth 39
Are margins and returns improving?
Cashflow 37
Earnings quality: real cash, not paper profit
Fin. Strength 51
Balance sheet, leverage, solvency risk
Investment 79
Disciplined investing over empire-building
Low Volatility 41
Calm price path (market factor)
Momentum 28
Price trend over the last 3–12 months (market factor)
52W Momentum 21
Distance to the 52-week high (market factor)
Net Issuance 80
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems.

Full company description

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables. The Communications Systems segment provides communications systems and accessories to support military communications systems, such as radio frequency amplifiers, power supplies and cables, connector assemblies, amplified speakers, equipment mounts, case equipment, man-portable systems, and integrated communication systems for fixed or vehicle applications comprising vehicle amplifier-adaptors, vehicle installed power enhanced rifleman appliqué systems, and SATCOM systems. This segment's military communications systems and accessories are designed to enhance and extend the operation of communications equipment, such as vehicle-mounted, manpack, and handheld transceivers. The company sells its products under the Ultralife, Ultralife HiRate, Ultralife Thin Cell, Lithium Power, McDowell Research, AMTI, ABLE, ACCUTRONICS, ACCUPRO, ENTELLION, SWE Southwest Electronic Energy Group, SWE SEASAFE, Excell Battery Group, Criterion Gauge, and POW-R BMS brands through original equipment manufacturers, and industrial and defense supply distributors. In addition, it sells its 9-volt battery to the broader consumer market through national and regional retail chains and online retailers. It serves government, defense, and commercial sectors. The company was incorporated in 1990 and is headquartered in Newark, New York.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Ultralife Corporation reported revenue of $191M in FY2025 versus $98.3M in FY2021, a compound +18.1%/yr. Reported net income was −$5.9M in FY2025.

Growth Quality 58/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
$191M
Latest YoY
+16.2%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+13.2%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+12.2%
Avg. growth/yr (34Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+15.3%
Revenue +18.1%/yr
FY21 $98.3M
FY22 $132M
FY23 $159M
FY24 $164M
FY25 $191M
Net income
FY21 −$234K
FY22 −$119K
FY23 $7.2M
FY24 $6.3M
FY25 −$5.9M
Character of growth · EPS growth decomposed (2015-2025) +9.3 % p.a.
Revenue per share +8.8 pp

of which total revenue +9.3 pp · buybacks/dilution −0.5 pp

EBIT margin +3.8 pp
Tax rate −2.3 pp
Residual (interest, one-offs) −0.9 pp

Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).

ULBI screens 21% overvalued. Compare with Contemporary Amperex Technology Co →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Ultralife Corporation Fair Value". https://www.fairvalue-calculator.com/stock/ULBI

Peer Group

Electrical Equipment & Parts · 526 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 48 · Below median
Fair Value upside −21% · Above median
Return on assets 2% · Below median
Net margin (TTM) -4% · Bottom 25%
Operating margin (TTM) 1% · Below median
Revenue growth -7% · Bottom 25%
Debt / equity 0.35× · Higher than 75% of peers

Valuation Multiples vs Electrical Equipment & Parts median · lower = cheaper

P/B 0.80× · Cheaper than 75% of peers
P/S (TTM) 0.55× · Cheaper than 75% of peers
P/FCF 14.6× · Pricier than 75% of peers
EV/EBITDA 12.7× · Cheaper than median
PEG 3.81× · Pricier than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 5 · sector 0
FUTURE 0 · sector 57
PAST 0 · sector 26
HEALTH 83 · sector 97
DIVIDEND 0 · sector 18

Insider activity: 55/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Electrical Equipment & Parts stocks, each showing price versus our Fair Value estimate (as of Jul 21, 2026).

Stock Price Fair Value vs Fair Value
Contemporary Amperex Technology Co 3750 HK$675.50 HK$391.44 -42%
ABB Ltd ABBN CHF 83.82 CHF 35.46 -58%
Delta Electronics (Thailand) Public Company TDED 10.16 SGD 1.47 SGD -86%
LG Energy Solution, Ltd 373220 334,000 KRW 201,455 KRW -40%
WEG S.A WEGE3 13,210 ARS 7,948 ARS -40%
Sungrow Power Supply Co 300274 ¥114.79 ¥123.83 +8%
Shenzhen Inovance Technology Co 300124 ¥63.43 ¥33.04 -48%
HD Hyundai Electric Co 267260 823,000 KRW 371,133 KRW -55%
LS ELECTRIC Co 010120 190,000 KRW 31,517 KRW -83%
Sieyuan Electric Co 002028 ¥151.73 ¥71.69 -53%

Compare Ultralife Corporation with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Ultralife Corporation (ULBI) overvalued or undervalued?
As of Jul 21, 2026, our model estimates a fair value of $5.02 versus a price of $6.35, about −21% (overvalued).
What is the fair value of ULBI?
Our model-based fair value for Ultralife Corporation is $5.02 (as of Jul 21, 2026), built from audited fundamentals. The current price is $6.35.
What is the quality score of ULBI?
Ultralife Corporation has a Quality Score of 48/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Ultralife Corporation (ULBI)?
Ultralife Corporation reported trailing-twelve-month revenue of about $188M (latest available figure, as of Jul 21, 2026).
What is the net profit margin of ULBI?
The net profit margin of Ultralife Corporation is about -4.4%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Ultralife Corporation and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.